MAPT and Alzheimer disease: Alterations in APP/Aβ and tau metabolism, mitochondrial dysfunctions, defects in axonal transport, synaptic remodeling, neuroinflammation are all pathophysiological changes detected in both AD and retinal decay [14, 126], enabling thus the interchange of knowledge in terms of underlying pathogenetic mechanisms and therapeutic intervention [16].